AI MARKET SCANNING

MacroGenics Inc

🏛️ NASDAQ 📁 Health Technology 🏭 Pharmaceuticals Major
AVG HISTORICAL GAP +2.90%
MAX GAP RECORD +21.75%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $MGNX
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Aug 13, 2026 Earnings Release 2026-08-13 (AFTER CLOSE)
-5.76%
May 13, 2026 Earnings Release 2026-05-13 (AFTER CLOSE)
+4.64%
Mar 09, 2026 Earnings Release 2026-03-09 (AFTER CLOSE)
+2.54%
Nov 12, 2025 Earnings Release 2025-11-12 (AFTER CLOSE)
+12.93%
Aug 14, 2025 Earnings Release 2025-08-14 (AFTER CLOSE)
-1.23%
May 13, 2025 Earnings Release 2025-05-13 (AFTER CLOSE)
-1.30%
Mar 20, 2025 Earnings Release 2025-03-20 (AFTER CLOSE)
-0.95%
Nov 05, 2024 Earnings Release 2024-11-05 (AFTER CLOSE)
+21.75%

VOLATILITY & GAP BIAS

AVG GAP MOVE 6.0%
Bullish Gaps (8)
Bearish Gaps (6)
Neutral / Flat (1)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $MGNX

EXECUTIONS0 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
Radar monitoring: awaiting next setup.
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

MacroGenics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of antibody-based therapeutics for the treatment of cancer. Its product pipeline includes Margetuximab, Flotetuzumab, Retifanlimab, Enoblituzumab, Tebotelimab, MGC018, MGD019, IMGC936, and MGD014 for infectious diseases. The company was founded by Scott E. Koenig, Jeffrey V. Ravetch, LeRoy…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗